Latest News
Latest News
Medical students gain momentum in effort to ban legacy admissions
Opponents of legacy admissions say it penalizes students from racial minorities and lower socioeconomic backgrounds, hampering a fair and...
Latest News
Five ways docs may qualify for discounts on medical malpractice premiums
Most states cap discounts at 25%, but some go as high as 70%.
Latest News
Part-time physician: Is it a viable career choice?
“Not only are more physicians seeking part-time roles than they were 10 years ago, but more large health care systems are also offering part time...
News from the FDA/CDC
New USPSTF draft suggests mammography start at 40, not 50
“It is now clear that screening every other year starting at age 40 has the potential to save about 20% more lives among all women.”
From the Journals
Familial cancer risk complex, not limited to same site
“The findings suggest that the familial risk extends to discordant early-onset cancers, including ovarian, testicular, and pancreatic cancers, as...
From the Journals
Pausing endocrine therapy to attempt pregnancy is safe
The results provide the “strongest evidence to date on the short-term safety of this choice.”
Latest News
Clinic responsible for misdiagnosing newborn’s meningitis, must pay millions
In a separate case, a Missouri doctor accused of incorrectly treating a woman’s embolism has been found not liable for her death.
Conference Coverage
Mammography after breast cancer: No benefit for older patients?
“Ongoing surveillance mammography in these patients may lead to overdiagnosis and overtreatment of cancers that potentially would not harm...
From the Journals
SCC from breast implants: Negligible risk, study finds
Regarding SCC, “whether the observed elevated risk is associated with the implants is difficult to interpret because it is based on only one case...
From the Journals
Adherence to cancer prevention guidance linked with reduced breast cancer recurrence, death risk
The study population included patients diagnosed with triple-negative breast cancer and HER2-positive breast cancer.
Latest News
Federal rules don’t require period product ingredients on packaging labels. States are stepping in.
The FDA regulates and classifies menstrual products as medical devices, meaning they are not subject to the same labeling laws as other consumer...